Company Filing History:
1 out of 1,145 
1 out of 133 
Years Active: 2016
Title: Kwan Soo Hong: Innovator in MRI Contrast Agents
Introduction
Kwan Soo Hong is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of medical imaging, particularly in the development of MRI contrast agents. His innovative work has the potential to enhance diagnostic capabilities in healthcare.
Latest Patents
Kwan Soo Hong holds a patent for a "Uridine-based gadolinium complex and MRI contrast agent including the same." This invention relates to a new uridine nucleoside-based amphiphilic gadolinium complex. The MRI contrast agent developed from this complex exhibits high relaxivity, high binding affinity for and stability in human serum albumin, pH response, and high liver specificity. This advancement is crucial for improving the effectiveness of MRI procedures.
Career Highlights
Throughout his career, Kwan Soo Hong has been associated with prominent research institutions. He has worked with the Korea University Research and Business Foundation and the Korea Basic Science Institute. His roles in these organizations have allowed him to contribute to significant advancements in scientific research and innovation.
Collaborations
Kwan Soo Hong has collaborated with esteemed colleagues, including Jong-Seung Kim and Sankarprasad Bhuniya. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical imaging.
Conclusion
Kwan Soo Hong's contributions to the development of MRI contrast agents highlight his innovative spirit and dedication to advancing medical technology. His work not only enhances diagnostic imaging but also paves the way for future research in the field.